Should MIGS be considered first-line therapy over eye drops?
Ocular Surgery News | In a 2020 position statement on microinvasive glaucoma surgery, the American Glaucoma Society said:“It is essential for researchers and industry to continue developing innovative therapeutic options that are effective at lowering IOP, possess a good safety profile, and are well tolerated by patients.”
Source: healio.com